These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27571924)

  • 1. Survival and complication rates in patients with thalassemia major in Taiwan.
    Wu HP; Lin CL; Chang YC; Wu KH; Lei RL; Peng CT; Weng T; Tai YM; Chao YH
    Pediatr Blood Cancer; 2017 Jan; 64(1):135-138. PubMed ID: 27571924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on thalassemia treatment in Taiwan, including bone marrow transplantation, chelation therapy, and cardiomyopathy treatment effects.
    Peng CT; Chang JS; Wang LY; Chiou SS; Hsiao CC; Wang SC; Hung GY; Wu KH
    Hemoglobin; 2009; 33(5):304-11. PubMed ID: 19814676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
    Maggio A; Vitrano A; Capra M; Cuccia L; Gagliardotto F; Filosa A; Magnano C; Rizzo M; Caruso V; Gerardi C; Argento C; Campisi S; Cantella F; Commendatore F; D'Ascola DG; Fidone C; Ciancio A; Galati MC; Giuffrida G; Cingari R; Giugno G; Lombardo T; Prossomariti L; Malizia R; Meo A; Roccamo G; Romeo MA; Violi P; Cianciulli P; Rigano P
    Blood Cells Mol Dis; 2009; 42(3):247-51. PubMed ID: 19233692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival, mortality, and complications in patients with beta-thalassemia major in northern Taiwan.
    Chern JP; Su S; Lin KH; Chang SH; Lu MY; Jou ST; Lin DT; Ho WL; Lin KS
    Pediatr Blood Cancer; 2007 May; 48(5):550-4. PubMed ID: 16972241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and complications in thalassemia.
    Borgna-Pignatti C; Cappellini MD; De Stefano P; Del Vecchio GC; Forni GL; Gamberini MR; Ghilardi R; Origa R; Piga A; Romeo MA; Zhao H; Cnaan A
    Ann N Y Acad Sci; 2005; 1054():40-7. PubMed ID: 16339650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.
    Caocci G; Orofino MG; Vacca A; Piroddi A; Piras E; Addari MC; Caria R; Pilia MP; Origa R; Moi P; La Nasa G
    Am J Hematol; 2017 Dec; 92(12):1303-1310. PubMed ID: 28850704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidities and mortality in transfusion-dependent Beta-thalassemia patients (single-center experience).
    Mokhtar GM; Gadallah M; El Sherif NH; Ali HT
    Pediatr Hematol Oncol; 2013 Mar; 30(2):93-103. PubMed ID: 23301991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece.
    Ladis V; Chouliaras G; Berdousi H; Kanavakis E; Kattamis C
    Ann N Y Acad Sci; 2005; 1054():445-50. PubMed ID: 16339695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of thalassemia treated with conventional therapy.
    Borgna-Pignatti C; Zurlo MG; DeStefano P; Boffa C; DeSanctis V; DiPalma A; DiGregorio L; Melevendi C; Piga A; Sabato V
    Bone Marrow Transplant; 1993; 12 Suppl 1():2-4. PubMed ID: 8374554
    [No Abstract]   [Full Text] [Related]  

  • 11. French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions.
    Galambrun C; Pondarré C; Bertrand Y; Loundou A; Bordigoni P; Frange P; Lutz P; Mialou V; Rubie H; Socié G; Schneider P; Bernaudin F; Paillard C; Michel G; Badens C; Thuret I; ;
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):62-8. PubMed ID: 22892550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications and treatment of patients with β-thalassemia in France: results of the National Registry.
    Thuret I; Pondarré C; Loundou A; Steschenko D; Girot R; Bachir D; Rose C; Barlogis V; Donadieu J; de Montalembert M; Hagege I; Pegourie B; Berger C; Micheau M; Bernaudin F; Leblanc T; Lutz L; Galactéros F; Siméoni MC; Badens C
    Haematologica; 2010 May; 95(5):724-9. PubMed ID: 20007138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta-thalassemia in Taiwan: A real-world analysis.
    Tang CH; Furnback W; Wang BCM; Tang J; Tang D; Lu MY; Huang VW; Musallam KM
    Transfusion; 2021 Oct; 61(10):2906-2917. PubMed ID: 34505291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.
    Casale M; Citarella S; Filosa A; De Michele E; Palmieri F; Ragozzino A; Amendola G; Pugliese U; Tartaglione I; Della Rocca F; Cinque P; Nobili B; Perrotta S
    Am J Hematol; 2014 Dec; 89(12):1102-6. PubMed ID: 25197009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-thalassemia: the Lebanese experience.
    Inati A; Zeineh N; Isma'eel H; Koussa S; Gharzuddine W; Taher A
    Clin Lab Haematol; 2006 Aug; 28(4):217-27. PubMed ID: 16898958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study on the "quality of life" as reflected by psychosocial adjustment of children with thalassemia major undergoing iron-chelating treatment in western Taiwan.
    Kuo HT; Tsai MY; Peng CT; Wu KH
    Hemoglobin; 2006; 30(2):291-9. PubMed ID: 16798654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 years.
    Poggi M; Sorrentino F; Pugliese P; Smacchia MP; Daniele C; Equitani F; Terlizzi F; Guitarrini MR; Monti S; Maffei L; Losardo A; Pasin M; Toscano V
    Ann Hematol; 2016 Apr; 95(5):757-63. PubMed ID: 26957357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic peripheral circulating blood stem cells as an independent marker of good transfusion management in patients with β-thalassemia: results from a preliminary study.
    Napolitano M; Gerardi C; Di Lucia A; Accardo PA; Rizzuto L; Ferraro M; Siragusa S; Buscemi F
    Transfusion; 2016 Apr; 56(4):827-30. PubMed ID: 26801519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and complications of thalassemia major in Guangxi, Southern China.
    Yin XL; Wu ZK; He YY; Zhou TH; Zhou YL; Zhang XH
    Pediatr Blood Cancer; 2011 Dec; 57(7):1174-8. PubMed ID: 21394896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.